机构

• 合肥物质科学研究院 [19]
• 武汉物理与数学研究所 [8]
• 上海药物研究所 [3]
• 植物研究所 [3]
• 近代物理研究所 [3]
• 宁波材料技术与工程研... [2]
• 更多

采集方式

• OAI收割 [49]

内容类型

• 期刊论文 [48]
• 会议论文 [1]

发表日期

• 2022 [11]
• 2021 [5]
• 2020 [4]
• 2019 [1]
• 2018 [4]
• 2017 [3]
• 更多

学科主题

• Plant Scie... [2]
• Biodiversi... [1]
• Cell Biolo... [1]
• Chemistry,... [1]
• Environmen... [1]
• 波谱学 [1]
• 更多

筛选

浏览/检索结果: 共49条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing;  Wang, Wenxian;  Xu, Chunwei   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 efficacy  immune-related adverse events  immunotherapy  thymoma   Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study 期刊论文  OAI收割 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wei, Jingwen;  Xiang, Jing;  Hao, Yue;  Si, Jinfei;  Wang, Wenxian   |  收藏  |  浏览/下载：29/0  |  提交时间：2022/12/22 Anemia  Epidermal growth factor receptor  Epidermal growth factor receptor tyrosine kinase inhibitors  Non-small cell lung cancer   Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文  OAI收割 EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174 作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23 Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Gu, Hongcang;  Zhang, Shirong;  He, Shutao;  Zhu, Xin;  Wang, Yunfei   |  收藏  |  浏览/下载：18/0  |  提交时间：2022/12/23 Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文  OAI收割 BMC MEDICINE, 2022, 卷号: 20 作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian   |  收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23 Thymic epithelial tumors  Apatinib  Efficacy  Toxicities   Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文  OAI收割 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文  OAI收割 TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11 作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan   |  收藏  |  浏览/下载：71/0  |  提交时间：2022/12/22 Non-small cell lung cancer (NSCLC)  HIVEP1-ALK  alectinib  intergenic region (IGR)  case report   Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文  OAI收割 GENES CHROMOSOMES & CANCER, 2022 作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping   |  收藏  |  浏览/下载：71/0  |  提交时间：2022/05/16 BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy